Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells
Open Access
- 25 February 2016
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 16 (1) , 1-10
Abstract
Hepatocellular carcinoma (HCC) is one of most common and aggressive human malignancies in the world, especially, in eastern Asia, and its mortality is very high at any phase. We want to investigate mechanism of niclosamide inducing cell apoptosis in HCC. Two hepatoma cell lines were used to evaluate activity of niclosamide inducing cell apoptosis and study its mechanism. Quantitative real-time PCR and western blotting were used in analysis of genes expression or protein active regulated by niclosamide. Niclosamide remarkably induced cell apoptosis in hepatoma cells. Furthermore, our study revealed that RNA-dependent protein kinase-like kinase (PERK) is activated and its expression is up-regulated in HCC cells which are exposed to niclosamide. niclosamide also significantly increase activating transcription factor 3 (ATF3), activating transcription factor 4 (ATF4) and CCAAT/enhancer-binding protein-homologous protein (CHOP) expression in HCC cells. It’s suggested that the function of niclosamide was abrogated by PERK inhibitor or absent ATF3. Expression of PERK and CHOP is correlated with ATF3 level in the cells. Taken together, our results indicate that ATF3 plays an integral role in ER stress activated and cell apoptosis induced by niclosamide in HCC cells. In this study, the new mechanism of niclosamide as anti-cancer we investigated, too.Keywords
Funding Information
- the National Natural and Science Foundation of China (81302825)
- the Shanghai Key Laboratory of Veterinary Biotechnology (klab201501)
This publication has 28 references indexed in Scilit:
- ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinomaOncotarget, 2014
- Low expression of activating transcription factor 3 in human hepatocellular carcinoma and its clinicopathological significancePathology - Research and Practice, 2014
- Niclosamide suppresses hepatoma cell proliferation via the Wnt pathwayOncoTargets and Therapy, 2013
- Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung CancerMolecular Cancer Therapeutics, 2013
- Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosisAutophagy, 2011
- Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC MutationsCancer Research, 2011
- Thapsigargin Induces Expression of Activating Transcription Factor 3 in Human Keratinocytes Involving Ca2+ Ions and c-Jun N-Terminal Protein KinaseMolecular Pharmacology, 2010
- AdipoR2 is transcriptionally regulated by ER stress‐inducible ATF3 in HepG2 human hepatocyte cellsThe FEBS Journal, 2010
- Activating Transcription Factor 3 Activates p53 by Preventing E6-associated Protein from Binding to E6Journal of Biological Chemistry, 2010
- Activating Transcription Factor 3 Is Integral to the Eukaryotic Initiation Factor 2 Kinase Stress ResponseMolecular and Cellular Biology, 2004